News in brief
Abzena invests $20m into two manufacturing suites at San Diego facility
Abzena announced it will expand its existing 500 L scale biologics equipment at its San Diego facility.
Archives for November 20, 2018
Lonza centers itself in Israel for innovation in biologic manufacturing
Lonza Pharma & Biotech established itself in Israel, with the opening of a collaborative hub aiming to advance manufacturing technology for cell and gene therapy commercialization.
DIA BIOSIMILARS CONFERENCE
WHO pushes for increased access to rituximab and trastuzumab biosimilars
A prequalification pilot designed to assess biosimilar versions of Roche’s Rituxan and Herceptin has attracted global interest from manufacturers, says WHO executive.